WBR1107: Difference between revisions
Jump to navigation
Jump to search
Matt Pijoan (talk | contribs) No edit summary |
m refreshing WBR questions |
||
Line 1: | Line 1: | ||
{{WBRQuestion | {{WBRQuestion | ||
|QuestionAuthor=William J Gibson (Reviewed by {{YD}}) | |QuestionAuthor=William J Gibson (Reviewed by {{YD}}) | ||
|ExamType=USMLE Step 1 | |ExamType=USMLE Step 1 | ||
|MainCategory=Pharmacology | |MainCategory=Pharmacology |
Latest revision as of 02:37, 28 October 2020
Author | [[PageAuthor::William J Gibson (Reviewed by Yazan Daaboul, M.D.)]] |
---|---|
Exam Type | ExamType::USMLE Step 1 |
Main Category | MainCategory::Pharmacology |
Sub Category | SubCategory::Pulmonology |
Prompt | [[Prompt::A 35-year-old man with HIV and documented trimethoprim-sulfamethoxazole allergy is placed on dapsone for pneumocystis prophylaxis when his CD4 count dropped below 200/mm3. Three weeks later, the patient presents to the emergency department with a 12-hour history of dyspnea, headache, dizziness, and blue discoloration of the lips and extremities. Pulse oximetry reveals an oxygen saturation of 82% on room air. When blood is drawn for arterial blood gas measurement, the nurse notices that it has a chocolate-brown color. Which of the following would be the most effective pharmacotherapy to manage this patient's condition?]] |
Answer A | AnswerA::Methylene blue |
Answer A Explanation | AnswerAExp::Methylene blue reverses methemoglobinemia. |
Answer B | AnswerB::Thiosulfate |
Answer B Explanation | AnswerBExp::Thiosulfate reverses methomglobinemia in cases of cyanide poisoning. However, in this case dapsone pharmacotherapy was responsible for this patient’s methomglobinemia. |
Answer C | AnswerC::N-acetylcysteine |
Answer C Explanation | AnswerCExp::N-acetylcysteine reverses the toxicity of acetaminophen overdose. |
Answer D | AnswerD::Naloxone |
Answer D Explanation | AnswerDExp::Naloxone reverses the effects of opiate overdose. |
Answer E | AnswerE::Vitamin C |
Answer E Explanation | AnswerEExp::Vitamin C can be effective in treating methemoglobinemia, but it is considered an ancillary therapy. |
Right Answer | RightAnswer::A |
Explanation | [[Explanation::Methemoglobinemia is a disorder characterized by the presence of a higher than normal concentration of methemoglobin (metHb, i.e., ferric [Fe3+] rather than ferrous [Fe2+] haemoglobin) in the blood. Methemoglobin is a form of hemoglobin that contains ferric [Fe3+] iron and has a decreased ability to bind oxygen. Methemoglobinemia can be treated with supplemental oxygen and methylene blue 1% solution (10 mg/ml) 1 to 2 mg/kg administered intravenously slowly over five minutes followed by IV flush with normal saline. Methylene blue restores the iron in hemoglobin to its normal (reduced) oxygen-carrying state. This is achieved by providing an artificial electron acceptor (such as methylene blue or flavin) for NADPH methemoglobin reductase (methylene blue allows the enzyme to be five-fold more active). The NADPH is generated via the hexose monophosphate shunt. Educational Objective: Methemoglobinemia can be treated with supplemental oxygen and methylene blue 1% solution. Methylene blue restores the iron in hemoglobin to its normal (reduced) oxygen-carrying state. |
Approved | Approved::Yes |
Keyword | WBRKeyword::Methemoglobinemia, WBRKeyword::Cyanosis, WBRKeyword::Blood, WBRKeyword::Oxygen, WBRKeyword::Pulmonary, WBRKeyword::Breathing, WBRKeyword::Lung, WBRKeyword::Hemoglobin |
Linked Question | Linked:: |
Order in Linked Questions | LinkedOrder:: |